Table 4

Mutations in the core promoter region (nt 1762 and 1764) in each genotype

DiagnosisGenotype AGenotype BGenotype CTotal
aNS; b p=0.005.
AH, acute self limited hepatitis; FH, fulminant hepatitis; CLD, chronic liver diseases.
AH0/4 (0%)1/13 (8.3%)6/20 (30.0%)7/37 (18.9%)a
FH1/1 (100%)2/10 (20.0%)2/4 (50.0%)5/15 (33.3%)a
Acute exacerbation of CLD0/0 (0%)0/4 (0%)8/13 (61.5%)8/17 (47.0%)
Total1/5 (20.0%)3/27 (11.1%)b16/37 (43.2%)b20/69 (29.0%)